Stem cell marker CD133 (PROMININ-1) is epigenetically regulated in ovarian cancer
Publication
, Conference
Baba, T; Convery, PA; Matsumura, N; Whitaker, RS; Perry, T; Huang, Z; Mori, S; Kondoh, E; Bentley, RC; Fujii, S; Marks, JR; Berchuck, A; Murphy, SK
Published in: GYNECOLOGIC ONCOLOGY
2008
Duke Scholars
Published In
GYNECOLOGIC ONCOLOGY
ISSN
0090-8258
Publication Date
2008
Volume
108
Issue
3
Start / End Page
S104 / S104
Related Subject Headings
- Oncology & Carcinogenesis
- 3215 Reproductive medicine
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1114 Paediatrics and Reproductive Medicine
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Baba, T., Convery, P. A., Matsumura, N., Whitaker, R. S., Perry, T., Huang, Z., … Murphy, S. K. (2008). Stem cell marker CD133 (PROMININ-1) is epigenetically regulated in ovarian cancer. In GYNECOLOGIC ONCOLOGY (Vol. 108, pp. S104–S104).
Baba, T., P. A. Convery, N. Matsumura, R. S. Whitaker, T. Perry, Z. Huang, S. Mori, et al. “Stem cell marker CD133 (PROMININ-1) is epigenetically regulated in ovarian cancer.” In GYNECOLOGIC ONCOLOGY, 108:S104–S104, 2008.
Baba T, Convery PA, Matsumura N, Whitaker RS, Perry T, Huang Z, et al. Stem cell marker CD133 (PROMININ-1) is epigenetically regulated in ovarian cancer. In: GYNECOLOGIC ONCOLOGY. 2008. p. S104–S104.
Baba, T., et al. “Stem cell marker CD133 (PROMININ-1) is epigenetically regulated in ovarian cancer.” GYNECOLOGIC ONCOLOGY, vol. 108, no. 3, 2008, pp. S104–S104.
Baba T, Convery PA, Matsumura N, Whitaker RS, Perry T, Huang Z, Mori S, Kondoh E, Bentley RC, Fujii S, Marks JR, Berchuck A, Murphy SK. Stem cell marker CD133 (PROMININ-1) is epigenetically regulated in ovarian cancer. GYNECOLOGIC ONCOLOGY. 2008. p. S104–S104.
Published In
GYNECOLOGIC ONCOLOGY
ISSN
0090-8258
Publication Date
2008
Volume
108
Issue
3
Start / End Page
S104 / S104
Related Subject Headings
- Oncology & Carcinogenesis
- 3215 Reproductive medicine
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1114 Paediatrics and Reproductive Medicine
- 1112 Oncology and Carcinogenesis